133 related articles for article (PubMed ID: 31788927)
1. One repressor to rule them all: ANCO1 links YAP and AIB1.
Zhang C; Moberg K
EMBO Rep; 2020 Jan; 21(1):e49647. PubMed ID: 31788927
[TBL] [Abstract][Full Text] [Related]
2. Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.
Kushner MH; Ory V; Graham GT; Sharif GM; Kietzman WB; Thevissen S; Yuan M; Schmidt MO; Wellstein A; Riegel AT
EMBO Rep; 2020 Jan; 21(1):e48741. PubMed ID: 31788936
[TBL] [Abstract][Full Text] [Related]
3. Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.
Garee JP; Chien CD; Li JV; Wellstein A; Riegel AT
Mol Endocrinol; 2014 Jun; 28(6):846-59. PubMed ID: 24678732
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.
Varešlija D; Ward E; Purcell SP; Cosgrove NS; Cocchiglia S; O'Halloran PJ; Charmsaz S; Bane FT; Brett FM; Farrell M; Cryan J; Beausang A; Hudson L; Turnbul AK; Dixon JM; Hill ADK; Priedigkeit N; Oesterreich S; Lee AV; Sims AH; Redmond AM; Carroll JS; Young LS
Oncogene; 2021 Feb; 40(7):1318-1331. PubMed ID: 33420368
[TBL] [Abstract][Full Text] [Related]
5. AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.
Kiliti AJ; Sharif GM; Martin MB; Wellstein A; Riegel AT
Front Endocrinol (Lausanne); 2023; 14():1250218. PubMed ID: 37711895
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells.
Li JV; Chien CD; Garee JP; Xu J; Wellstein A; Riegel AT
Mol Endocrinol; 2013 Jul; 27(7):1113-27. PubMed ID: 23660594
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
[TBL] [Abstract][Full Text] [Related]
8. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
[TBL] [Abstract][Full Text] [Related]
9. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
10. Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer.
Shi J; Liu W; Sui F; Lu R; He Q; Yang Q; Lv H; Shi B; Hou P
Oncotarget; 2015 Jun; 6(16):14344-59. PubMed ID: 25970779
[TBL] [Abstract][Full Text] [Related]
11. AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation.
Wang M; Zhao F; Li S; Chang AK; Jia Z; Chen Y; Xu F; Pan H; Wu H
PLoS One; 2013; 8(6):e65556. PubMed ID: 23762395
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional repression of the tumor suppressor DRO1 by AIB1.
Ferragud J; Avivar-Valderas A; Pla A; De Las Rivas J; Font de Mora J
FEBS Lett; 2011 Oct; 585(19):3041-6. PubMed ID: 21871888
[TBL] [Abstract][Full Text] [Related]
13. Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.
Chien CD; Kirilyuk A; Li JV; Zhang W; Lahusen T; Schmidt MO; Oh AS; Wellstein A; Riegel AT
J Biol Chem; 2011 Jul; 286(30):26813-27. PubMed ID: 21636853
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
15. The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ.
Ory V; Tassi E; Cavalli LR; Sharif GM; Saenz F; Baker T; Schmidt MO; Mueller SC; Furth PA; Wellstein A; Riegel AT
Oncogene; 2014 Jun; 33(23):3033-42. PubMed ID: 23851504
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cell Phenotypes in ER
Truong TH; Hu H; Temiz NA; Hagen KM; Girard BJ; Brady NJ; Schwertfeger KL; Lange CA; Ostrander JH
Mol Cancer Res; 2018 Apr; 16(4):707-719. PubMed ID: 29348189
[TBL] [Abstract][Full Text] [Related]
17. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.
Kuang SQ; Liao L; Zhang H; Lee AV; O'Malley BW; Xu J
Cancer Res; 2004 Mar; 64(5):1875-85. PubMed ID: 14996752
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
[No Abstract] [Full Text] [Related]
19. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
[TBL] [Abstract][Full Text] [Related]
20. Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.
Azorsa DO; Cunliffe HE; Meltzer PS
Breast Cancer Res Treat; 2001 Nov; 70(2):89-101. PubMed ID: 11768608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]